Melatonin vs NMN for longevity
Short answer: For longevity, users rate them about the same: 100% report improvement with Melatonin (7 reports) and 100% with NMN (12 reports).
Melatonin has 688 meta-analyses and 1,128 randomized trials on PubMed; NMN has 11 and 17.
Based on 1,370 reports about Melatonin and 366 about NMN. Not medical advice.
| Melatonin Supplement | NMN Supplement | |
|---|---|---|
| Users say it helped | 42%helped726 reports · high confidence | 61%helped113 reports · high confidence |
| Verdict | Mixed | Mostly positive |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 688 / 1,128 | 11 / 17 |
| Mainly used for | ||
| Sleep % reporting improvement | 78% (915) | 65% (20) |
| Energy % reporting improvement | 32% (25) | 92% (77) |
| Mood % reporting improvement | 32% (37) | 100% (13) |
| Focus % reporting improvement | 38% (8) | 83% (12) |
| Longevity % reporting improvement | 100% (7) | 100% (12) |
| Common side effects | drowsiness, vivid dreams, fatigue, depression | insomnia, jitteriness, drowsiness, elevated blood |
| Typical dose reported | 0.5 mg / bedtime | 1 g / daily |
Overall, eszopiclone and lemborexant had a favorable profile, but eszopiclone might cause substantial adverse events and safety data on lemborexant were inconclusive. Doxepin, seltorexant, and zaleplon were well tolerated, but data on efficacy and other important outcomes were scarce and do not allow firm conclusions. Many licensed drugs (including benzodiazepines, daridorexant, suvorexant, and trazodone) can be effective in the acute treatment of insomnia but are associated with poor tolerability, or information about long-term effects is not available. Melatonin, ramelteon, and non-licensed
Lancet, 2022 ↗“I have taken it nightly for 19 years. Doses ranging from .1 to 10mg. Right now I take 3mg per night. It helps me sleep.”
Overall, NAD⁺ augmentation shows clear biological activity, but clinical effectiveness for anti-aging or wellness outcomes remains inconclusive. Larger, well-designed randomized trials with longer follow-up and prespecified clinically meaningful endpoints are needed, particularly for parenteral approaches.
Ageing Res Rev, 2026 ↗“I've been using NMN for 3 years now, and I had great results with it along with many other supplements. I'm 47 and I look a lot younger and healthier than when I first started NMN.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate